Evaluating the Effect of Hemolysis, Icterus, and Lipemia on Chemistry Assays
Experts from Medpace’s central laboratory evaluated the effect of hemolysis, icterus and lipemia on chemistry assays and assessed the association between the amount of interfering…
State of the Art Flow Cytometry Techniques Now Supported in Singapore
Medpace offers global flow cytometry capabilities, with flow cytometry departments located at our US, Belgium and Singapore central laboratories.
New Biomarker Assay Validations from Medpace’s Central Labs
With an already robust menu of validated assays, the increase in new biomarker assay validations speaks to the seamless service we provide to our Sponsors.
Medpace Expands Production Capabilities for Collection Kits
As part of our mission to deliver superb customer service and site support, we have recently expanded our kit building capabilities in the US and…
Medpace’s Biorepository Services: Expansion and Highlights
In this post, we highlight some of the key investments we have made in each of our biorepositories around the world and what that means…
Molecular Capabilities and Genetic Laboratory Expansion
With the advancement of precision medicine, molecular and genetic testing is becoming a critical component for patient selection and individual assessment of the risks and…
Medpace Harmonizes Global Data across Its Regional Laboratories
Data from central laboratories have been key for assessing safety, tolerability, and efficacy of new drugs in clinical trials. With the increasing complexity and global…
Biomarkers for Celiac Disease Clinical Trials
As a full service, global CRO with an integrated central lab, Medpace has the scientific, operational and regulatory expertise to manage your celiac disease clinical…
Medpace and IHMA Announce Strategic Alliance to Provide Microbiology Laboratory Services for Clinical Studies
Medpace, a global full service Contract Research Organization (CRO) and International Health Management Associates, Inc. (IHMA), a full service central...